|Systematic (IUPAC) name|
|Half-life||10-48 hrs (~20 hrs)|
|Mol. mass||308.40 g/mol|
Deschloroetizolam is a thienodiazepine which is a benzodiazepine analog, closely related to etizolam (Etilaam), triazolam (Halcion), and alprazolam (Xanax). It first appeared in grey market channels in 2014.
Like other drugs of its class, it possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is expected to be about half as potent and twice as long lasting as etizolam, based upon the analogy between triazolam and alprazolam.
Deschloroetizolam is predicted to have an equivalence of 2 mg to 10 mg diazepam. It is expected to have a similar bioavailibility, similar time to onset, and longer elimination half life than its parent drug, etizolam.
- THIENYLAZOLE COMPOUND AND THIENOTRIAZOLODIAZEPINE COMPOUND. Patent EP 0776892. Yoshitomi Pharmaceuticals, 1997.
- "Deschloro-etizolam: a new thienodiazepine research chemical". bluelight.ru. Retrieved 21 July 2014.